[A real world study on the relationship between drug resistance of targeted therapy and prognosis of HER-2-positive advanced breast cancer]

Objective: To explore the effect of primary and acquired resistance to anti-human epidermal growth factor receptor 2 (HER-2) on the overall survival of patients with HER-2 positive advanced breast cancer. Methods: The clinical characteristics of HER-2 positive patients with advanced breast cancer admitted to Cancer Hospital of Chinese Academy of Medical Sciences from January 1998 to December 2018 were collected, and their neoadjuvant/adjuvant and advanced three-line chemotherapy were summarized. Among them, targeted drugs for HER-2 included trastuzumab, pertuzumab, T-DM1, RC48-ADC, lapatinib, pyrotinib, allitinib, sipatinib, seratinib. Based on the duration of benefit from anti HER-2 treatment, the patients were divided into two groups: primary anti HER-2 resistance group and acquired anti HER-2 resistance group. In this study, the overall survival (OS) was used as the main end point. Kaplan-Meier analysis and Cox proportional risk regression model were used to analyze the effects of different drug resistance mechanisms on the overall survival. Results: The whole group of 284 patients were included. The median age of recurrence and metastasis was 48 years old, 155 (54.6%) were hormone receptor (HR) positive and 129 (45.4%) were HR negative, 128 cases (45.1%) were premenopausal and 156 cases (54.9%) were postmenopausal, 277 cases (97.5%) had a score of 0-1 in ECoG PS and 7 cases (2.5%) had a score of more than 2 in the first diagnosis of relapse and metastasis. There were 103 cases (36.3%) in the primary drug resistance group and 181 cases (63.7%) in the secondary drug resistance group. The median overall survival time of the two groups was 24.9 months and 40.4 months, respectively, with statistical significance (P<0.001). Conclusion: Primary resistance to HER-2 is one of the factors of poor prognosis in HER-2 positive breast cancer, and its mechanism needs to be further explored.

[Exploration of the high-risk factors of catheter-related thrombosis in breast cancer]

Objective: To explore the high risk factors of catheter-related thrombosis (CRT) in breast cancer patients, and provide the basis for the development of appropriate prevention and treatment strategies. Methods: A total of 1 432 breast cancer patients scheduled to receive central venous catheterization in National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College from January 1, 2015 to August 31, 2019 were selected. Baseline information and catheterization information of patients were collected. The occurrence of CRT was confirmed by vascular ultrasound examination, and the influencing factors of CRT were analyzed. Results: The total number of catheter days were 121, 980 days in 1 432 patients with breast cancer, and the average number of catheter days in each patient was 85.2 days. The incidence of CRT was 6.8% (97/1 432), which was 0.79 cases/1 000 catheter days. Among 815 patients with centrally inserted central venous catheters (CICC), 43 (5.3%) had CRT, which was 0.70 cases/1 000 catheter days. Among 617 patients with peripherally inserted central venous catheters (PICC), 54 (8.8%) developed CRT, which was 0.90 cases/1 000 catheter days. CRT was most common in subclavian vein (63.9%). Multivariate regression analysis showed that age ≥ 60 years old (OR=1.712, 95% CI: 1.056-2.775, P=0.029), PICC (OR=1.732, 95% CI: 1.130-2.656, P=0.012), the catheter position except subclavian vein (OR=10.420, 95% CI: 1.207-89.991), secondary adjustment of catheter position (OR=3.985, 95% CI: 1.510-10.521, P=0.005) and high D-Dimer level (OR=1.129, 95% CI: 1.026-1.241, P=0.012)were independent risk factors for CRT. Conclusions: The CRT problem can't be ignored in the clinical treatment of breast cancer patients with central venous catheterization. Screening the appropriate age of patients and the type of central venous catheters, reducing the secondary adjustment of catheter position, and timely monitoring the level of D-dimer are helpful to the prevention and treatment of CRT.

A novel supramolecular AIE π-gel for fluorescence detection and separation of metal ions from aqueous solution

A novel supramolecular aggregation induced emission (AIE) π-gel (ONT) was constructed by using a functionalized trimesic amide (TCP) molecule assembled with a bis-pyridine functionalized naphthalene diimide (ND) molecule using a non-covalent interaction. The ONT showed strong AIE at 468 nm. Furthermore, the ONT could detect and adsorb ferric (Fe³⁺) or cupric (Cu²⁺) ions from water. Meanwhile, a thin film based on supramolecular AIE π-gel ONT was prepared, which could be used as a fluorescent security display material for detecting Fe³⁺ or Cu²⁺. Thus, the AIE π-gel ONT shows potential for practical applications in efficient multi-analyte detection and separation and as a fluorescent display material.

Rationally introduce AIE into chemosensor: A novel and efficient way to achieving ultrasensitive multi-guest sensing

Recently, ultrasensitive detection and multi-guest sensing have received extensive attention due to their high sensitivity and efficiency. Herein, we report a novel approach to achieve ultrasensitive detection of multi-analyte. This approach is concluded as "rationally introduce Aggregation-Induced Emission (AIE) into chemosensor". According to this approach, by rationally introducing self-assembly moiety, the obtained chemosensor DNS could serve as a novel AIEgen and show strong AIE in DMSO/H₂O (water fraction 80%) binary solution. Interestingly, a simple fluorescent sensor array based on the DNS has been developed. This sensor array could selectively sense Fe³⁺, Al³⁺, H₂PO₄^- and L-Arg in water solution. More importantly, this sensor array shows ultrasensitive detection for Fe³⁺, Al³⁺ and L-Arg. The LODs of the sensor array for Fe³⁺, Al³⁺ and L-Arg are in the range of 3.54×10^-9M to 9.42×10^-9M. Moreover, H₂PO₄^- could realize the reversible detection of Fe³⁺ in the DMSO/H₂O (water fraction 80%) solution. Meanwhile, DNS-based test papers and thin films were prepared, which could serve as test kits for convenient detection Fe³⁺, Al³⁺, and L-Arg in water. In addition, they could also act as efficient erasable fluorescent display materials.

Pillar[5]arene-based spongy supramolecular polymer gel and its properties in multi-responsiveness, dye sorption, ultrasensitive detection and separation of Fe3

Herein, a novel way to design and construct multi-functional spongy supramolecular polymer gels through an easy to make tripodal guest (TA) and a naphthalimide functionalized-pillar[5]arene host (AP5) has been developed. According to this approach, a novel pillar[5]arene-based supramolecular polymer gel (SHG) was constructed via multi-non-covalent interactions such as host-guest inclusion, C-Hπ, ππ and hydrogen bonds and so on. Interestingly, the SHG exhibits a spongy structure and strong aggregation induced emission (AIE). Furthermore, the SHG also exhibited multi-responsiveness toward outer stimuli such as heating-cooling, pH, competitive agents and mechanical. More importantly, the SHG xerogel shows separation properties for Fe3+, methyl orange, methylene blue and sudan I dyes. The separation rates of SHG xerogel for Fe3+ ions and organic dyes can reach up to 99.8%. Simultaneously, the SHG could ultrasensitively detect Fe3+ (LOD is 0.9 nM). In addition, a thin film based on SHG was also prepared, which was confirmed to be a convenient test kit for detecting Fe3+.

Forming a water-soluble supramolecular polymer and an AIEE hydrogel: two novel approaches for highly sensitive detection and efficient adsorption of aldehydes

Two novel approaches for highly sensitive detection and efficient adsorption of aldehydes by forming a water-soluble supramolecular polymer and an AIEE hydrogel.

A novel supramolecular polymer π-gel based on bis-naphthalimide functionalized-pillar[5]arene for fluorescence detection and separation of aromatic acid isomers

A pillar[5]arene-based supramolecular polymer π-gel, BPN-G, can selectively identify and separate benzoic acid isomers through rationally introduced multi-intermolecular interactions.

Anion induced supramolecular polymerization: a novel approach for the ultrasensitive detection and separation of F−

A novel approach for the ultrasensitive detection and separation of F⁻ has been developed. F⁻ could induce a tripodal naphthalimide sensor (TNA) to carry out reversible supramolecular polymerization and lead to strong AIEE.

A tripodal supramolecular sensor to successively detect picric acid and CN− through guest competitive controlled AIE

Herein, we report a simple and efficient method for the selective and sensitive detection of picric acid (PA) and CN⁻via a novel guest competitive controlled aggregation-induced emission (AIE) mechanism based on a tris-naphthalimide derivative TG.

Acylhydrazone functionalized benzimidazole-based metallogel for the efficient detection and separation of Cr3

Chromium(iii) is a kind of microelement and can be converted to the more toxic chromium(vi), which is a carcinogen, by redox cycling. Thus, the development of novel materials for the detection and removal of Cr³⁺ is a very important issue. A novel metallogel chemosensor (BMG-Fe) based on functionalized benzimidazole (BM) and Fe³⁺ was constructed, which could fluorescently detect and separate Cr³⁺. The detection limit of BMG-Fe for Cr³⁺ is 2.62 × 10^-8 M, and it exhibited high sensitivity and selectivity for Cr³⁺. Meanwhile, the absorbing percentage of BMG-Fe for Cr³⁺ is 96.36%, indicating a high separation rate. Interestingly, the sensitivity and ingestion capacity of BMG-Fe for Cr³⁺ are better than that of the simple organogel (BMG). So, the metallogel BMG-Fe could be utilized for the efficient removal of heavy metal ions from waste water.

A novel supramolecular AIE gel acts as a multi-analyte sensor array

Supramolecular gelator WJ could form a stable supramolecular organogel (WJG) with strong aggregation-induced emission (AIE). Utilizing the AIE gel, we successfully developed a multi-analyte sensor array which could accurately identify CN⁻, Al³⁺, and Fe³⁺ and l-Cys.

Investigation of the anti-angiogenesis effects induced by deoxypodophyllotoxin-5-FU conjugate C069 against HUVE cells

We have found that the deoxypodophyllotoxin-5-fluorouracil conjugate, 4'-O-demethyl-4-deoxyppodophyllotoxin-4'-yl 4-((6-(2-(5-fluorouracil-yl)acetamido) hexyl)amino)-4-oxobutanoate (C069), possessed superior cytotoxicities and less toxicity compared with etoposide. In this paper, the anti-angiogenic and vascular disrupting activities of C069 were examined with several in vitro and in vivo models. First, we demonstrated that C069 significantly inhibited the proliferation, migration, tube formation and disrupted the formed tube-like structures of HUVE cells, and inhibited angiogenesis in chicken chorioallantoic membrane assay. Furthermore, we found that C069 inhibited tube formation of HUVE cells by down-regulating the MMP-2, MMP-9, and phosphorylation of Akt and β-catenin. These results provided the initial evidence that C069 exerts potent anti-angiogenic and vascular disrupting effects.

Synthesis of hybrid 4-deoxypodophyllotoxin-5-fluorouracil compounds that inhibit cellular migration and induce cell cycle arrest

A series of deoxypodophyllotoxin-5-fluorouracil hybrid compounds were synthesized, and their cytotoxic activity was evaluated using four human cancer cell lines (HeLa, A549, HCT-8, and HepG2) and the human normal cell line WI-38. The synthesized compounds exhibited greater cytotoxic activity in tumor cells and reduced toxicity in the normal cell line compared with the anticancer drug VP-16 and 5-FU. Additionally, the most potent of these compounds-4'-O-demethyl-4-deoxypodophyllotoxin-4'-yl 4-((6-(2-(5-fluorouracil-yl) acetamido) hexyl) amino)-4-oxobutanoate (compound 22)-induced cell-cycle arrest in the G2/M phase by regulating levels of cdc2, cyclinB1, and p-cdc2 in A549 cells. Furthermore, compound 22 may inhibited the migration of A549 cells via down-regulation of MMP-9 and up-regulation of TIMP-1.

Magnetic phase transitions in one-dimensional strongly attractive three-component ultracold fermions

We investigate the nature of trions, pairing, and quantum phase transitions in one-dimensional strongly attractive three-component ultracold fermions in external fields. Exact results for the ground-state energy, critical fields, magnetization and phase diagrams are obtained analytically from the Bethe ansatz solutions. Driven by Zeeman splitting, the system shows exotic phases of trions, bound pairs, a normal Fermi liquid, and four mixtures of these states. Particularly, a smooth phase transition from a trionic phase into a pairing phase occurs as the highest hyperfine level separates from the two lower energy levels. In contrast, there is a smooth phase transition from the trionic phase into a normal Fermi liquid as the lowest level separates from the two higher levels.